# Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy

> **NCT00129142** · PHASE3 · COMPLETED · sponsor: **GTx** · enrollment: 1200 (—)

## Conditions studied

- Prostate Cancer
- Osteoporosis
- Fractures

## Interventions

- **DRUG:** Toremifene Citrate

## Key facts

- **NCT ID:** NCT00129142
- **Lead sponsor:** GTx
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 1200 (—)
- **Last updated:** 2013-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00129142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00129142, "Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT00129142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*